Ferosoft-S Iv Injection 100Mg (1 Box = 5 Ampoules)

Name: Ferosoft-S Iv Injection 100Mg (1 Box = 5 Ampoules)
Brand: HILTON PHARMA
Price: 1881.0

Brand : hilton pharma

Rs. 1,881.00

Rs. 1,980.00

|

QUICK DELIVERY

Ferosoft-S Iv Specification

Requires Prescription (YES/NO)

Yes

Generics

Ferric sucrose complex

Used For

Fluids & Electrolytes

How it works

Ferric sucrose injection is in a class of medications called iron replacement products. It works by replenishing iron stores so that the body can make more red blood cells.

Ferosoft-S Iv Usage And Safety

Dosage

Ferric sucrose complex

Side Effects

Cardiac Arrthymias .

Drug Interactions

As with all parenteral iron preparations, iron sucrose should not be administered concomitantly with oral iron preparations since the absorption of oral iron is reduced. Therefore, oral iron therapy should be started at least 5 days after the last injection of Iron Sucrose.

Indication

Iron deficiency in cases where oral iron cannot be provided .

When not to Use

The use of ferric sucrose is contra-indicated in cases of: - Known hypersensitivity to iron sucrose or any of its components. - Anemias not attributable to iron deficiency. - Iron overload or disturbances in utilization of iron. - Patients with a history of asthma, eczema or other atopic allergy, because they are more susceptible to experience allergic reactions. - Pregnancy first trimester .

Ferosoft-S Iv Precautions

Precaution

Parenteral administered iron preparations can cause allergic or anaphylactoid reactions, which may be potentially fatal. Therefore, treatment for serious allergic reactions and facilities with the established cardio-pulmonary resuscitation procedures should be available.

Ferosoft-S Iv Warnings

Warning 1

In patients with liver dysfunction, parenteral iron should only be administered after careful risk/benefit assessment. Parenteral iron administration should be avoided in patients with hepatic dysfunction where iron overload is a precipitating factor, in particular Porphyria Cutanea Tarda (PCT). Careful monitoring of iron status is recommended to avoid iron overload .

Warning 2

Parenteral iron must be used with caution in case of acute or chronic infection. It is recommended that the administration of iron sucrose is stopped in patients with ongoing bacteremia. In patients with chronic infection a risk/benefit evaluation has to be performed, taking into account the suppression of erythropoiesis .

Warning 3

Hypotensive episodes may occur if the injection is administered too rapidly. Allergic reactions, sometimes involving arthralgia, have been more commonly observed when the recommended dose is exceeded .

Download the Dvago App